Attached files

file filename
8-K - 8-K - IMAX CORPd919003d8k.htm

IMAX CORPORATION

Exhibit 99.1

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS

HIGHLIGHTS

 

  -   Strong film performance along with expanded margins result in over 50% growth in adjusted net income after non-controlling interest in Q1 2015 compared to Q1 2014

 

  -   First quarter revenues increase 29% from prior year period to $62.2 million, driven by strong box office and higher installations

 

  -   Q1 2015 box office of $166 million, up 20% from Q1 2014, with 64% generated from international markets

 

  -   Strategic initiatives such as roll-out of laser system, recent long-term film deals with Disney and Warner Brothers, new theatre signings and strong theatre openings position Company well for future growth

NEW YORK, NY – Apr. 30, 2015 – IMAX Corporation (NYSE:IMAX) today reported first quarter 2015 revenues of $62.2 million, adjusted EBITDA as calculated in accordance with the Company’s credit facility of $16.0 million, adjusted net income after non-controlling interest of $5.0 million, or $0.07 per diluted share, and reported net income after non-controlling interest of $0.4 million, or $nil per diluted share. The Company also reported a first quarter global per screen average of $202,900.

“This is a very exciting time for IMAX,” said IMAX CEO Richard L. Gelfond. “Our continued progress in expanding our theatre network globally, along with our strong film performance during the first quarter, resulted in robust financial results with almost 30% revenue growth and over 50% adjusted earnings growth compared to the same period last year. With record results from Furious 7 in April and a great start to the Avenger’s sequel internationally, the momentum has continued into the second quarter.”

Network Growth Update

The total IMAX® theatre network consisted of 943 systems as of March 31, 2015, of which 820 were in commercial multiplexes. There were 403 theatres in backlog as of March 31, 2015, compared to 431 in backlog as of March 31, 2014. In the first quarter of 2015, the Company signed contracts for 21 theatres, of which 20 were for new locations and 1 was for an upgrade. In the quarter, the Company also installed 13 theatres, of which 11 were for new theatre locations and 2 were upgrades. For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.

“The year has gotten off to a very positive start with film performance, network expansion, technology advancements and openings in new markets, all showing promise,” continued Gelfond. “With the successful launch of our laser system to rave reviews, our recent long-term movie deals with Disney and Warner Brothers, our installation pace and new signings and strong box office results so far this year – we continue to solidify our leading position in the entertainment ecosystem and set the stage for future long-term growth.”

 

1


First-Quarter Segment Results

 

    Revenue from sales and sales-type leases was $8.6 million in the first quarter of 2015, compared to $4.5 million in the first quarter of 2014, primarily reflecting the installation of 5 full, new theatre systems under sales and sales-type lease arrangements in the most recent first quarter, compared to the 3 sales-type theatres the Company installed in the first quarter of 2014. In addition, there were 2 digital system upgrades (1 sale and 1 operating lease) in existing locations in the first quarter of 2015, compared to 2 upgrades (1 sale and 1 joint revenue-sharing) in the first quarter of 2014.

 

    Revenue from joint revenue-sharing arrangements was $15.9 million in the quarter, compared to $10.9 million in the prior-year period. During the quarter, the Company installed 6 new theatres under joint revenue-sharing arrangements, compared to 5 in 2014. The Company had 457 theatres operating under joint revenue-sharing arrangements as of March 31, 2015, as compared to 388 joint-venture theatres one year prior.

 

    Production and IMAX DMR® (Digital Re-Mastering) revenues were $17.7 million in the first quarter of 2015, compared to $15.2 million in the first quarter of 2014. Gross box office from DMR titles was $165.6 million in the first quarter of 2014, compared to $138.5 million in the prior-year period. The average global DMR box office per screen in the first quarter of 2014 was $202,900 compared to $197,000 in the prior-year period.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its first quarter 2015 financial results. To access the call via telephone, interested parties in the US and Canada should dial (800) 524-8950 approximately 5 to 10 minutes before the call begins. International callers should dial (416) 260-0113. The conference ID for the call is 1956369. A replay of the call will be available via webcast on the ‘Investor Relations’ section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 1956369.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of March 31, 2015, there were 943 IMAX theatres (820 commercial multiplexes, 18 commercial destinations and 105 institutions) in 63 countries.

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, general economic, market or business conditions; the opportunities (or lack thereof) that may be presented to and pursued by the Company; the performance of IMAX DMR films; competitive actions by other companies; conditions in the in-home and out-of-home entertainment industries; the signing of theater system agreements; changes in laws or regulations; conditions, changes and developments in the commercial exhibition industry; the failure to convert theater system backlog into revenue; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the failure to respond to change and advancements in digital technology; risks related to the acquisition of AMC Entertainment Holdings, Inc. by Dalian Wanda Group Co., Ltd.; risks related to new business initiatives; the potential impact of increased competition in the markets within which the Company operates; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to Eastman Kodak bankruptcy and the possibility of constrained film supply; risks related to the Company’s

 

2


implementation of a new enterprise resource planning system; risks related to the Company’s prior restatements and the related litigation; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

 

Investors:

IMAX Corporation, New York

Teri Loxam

212-821-0100

tloxam@imax.com

 

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

 

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

 

Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

3


Additional Information

Signings and Installations

 

 

Mar. 31, 2015

 

     Three Months
Ended Mar. 31,
 
     2015     2014  

Theater Signings:

    

Full new sales and sales-type lease arrangements

     12        32  (1) 

New joint revenue sharing arrangements

     8        3   
  

 

 

   

 

 

 

Total new Theaters

  20      35   

Upgrades of IMAX Theater systems

  1      1   
  

 

 

   

 

 

 

Total Theater Signings

  21      36   
  

 

 

   

 

 

 
     Three Months
Ended Mar. 31,
 
     2015     2014  

Theater Installations:

    

Full new sales and sales-type lease arrangements

     5        3   

New joint revenue sharing arrangements

     6        5   
  

 

 

   

 

 

 

Total new Theaters

  11      8   

Upgrades of IMAX Theater systems

  2  (2)    2   
  

 

 

   

 

 

 

Total Theater Installations

  13      10   
  

 

 

   

 

 

 
     As of Mar. 31,  
     2015     2014  

Theater Backlog:

    

New sales and sales-type lease arrangements

     160        151   

New joint revenue sharing arrangements

     218        257   
  

 

 

   

 

 

 

Total new Theaters

  378      408   

Upgrades of IMAX Theater systems

  25      23   
  

 

 

   

 

 

 

Total Theaters in Backlog

  403  (3)(4)    431  (3)(5) 
  

 

 

   

 

 

 
     As of Mar. 31,  
     2015     2014  

Theater Network:

    

Commercial Multiplex Theaters:

    

Sales and sales-type lease arrangements

     363        319   

Joint revenue sharing arrangements

     457        388   
  

 

 

   

 

 

 

Total Commercial Multiplex Theaters

  820      707   

Commercial Destination Theaters

  18      18   

Institutional Theaters

  105      115   
  

 

 

   

 

 

 

Total IMAX Theater Network

  943      840   
  

 

 

   

 

 

 

 

(1) Includes three signings which replaced theaters under an existing arrangement in backlog.
(2) Includes one upgrade to a laser-based digital system in an existing IMAX theater location.
(3) Includes 69 laser theater system configurations (2014 – 64), including upgrades. The Company continues to develop and roll out its laser projection system.
(4) Includes 25 upgrades to a digital theater system in existing IMAX theater locations (2 xenon and 23 laser, of which 5 are under joint revenue sharing arrangements).
(5) Includes 23 upgrades to a digital theater system in existing IMAX theater locations (3 xenon and 20 laser, of which 4 are under joint revenue sharing arrangements).

 

4


Additional Information (continued)

 

2015 DMR Films:

In addition to the 13 IMAX DMR films released to the IMAX theater network during the first three months of 2015, 18 additional IMAX DMR films have been announced so far to be released in the remaining nine months of 2015:

 

    Furious 7: The IMAX Experience (Universal Studios, April 2015);

 

    The Water Diviner: The IMAX Experience (Warner Bros. Pictures, April 2015);

 

    Dragon Ball Z: Revival of ‘F’: An IMAX 3D Experience (Toei Animation, April 2015, Japan only);

 

    The Avengers: Age of Ultron: An IMAX 3D Experience (Walt Disney Studios, May 2015);

 

    Tomorrowland: The IMAX Experience (Walt Disney Studios, May 2015);

 

    Jurassic World: An IMAX 3D Experience (Universal Studios, June 2015);

 

    Ant-Man: An IMAX 3D Experience (Walt Disney Studios, July 2015);

 

    Terminator Genisys: The IMAX Experience (Paramount Pictures, July 2015);

 

    Mission: Impossible 5: The IMAX Experience (Paramount Pictures, July 2015);

 

    The Man from U.N.C.L.E: The IMAX Experience (Warner Bros. Pictures, August 2015);

 

    Crouching Tiger, Hidden Dragon: The Green Legend: The IMAX Experience (China Film Group, August 2015);

 

    Everest: An IMAX 3D Experience (Universal Studios, September 2015);

 

    The Walk: The IMAX Experience (Sony Pictures Entertainment, October 2015);

 

    Crimson Peak: The IMAX Experience (Universal Studios, October 2015);

 

    Spectre : The IMAX Experience (Sony Pictures Entertainment, November 2015);

 

    The Hunger Games: Mockingjay Part 2: An IMAX 3D Experience (Lionsgate, November 2015);

 

    In the Heart of the Sea: The IMAX Experience (Warner Bros. Pictures, December 2015); and

 

    Star Wars: The Force Awakens: An IMAX 3D Experience (Walt Disney Studios, December 2015).

To date, the Company has announced the following 14 titles to be released to the IMAX theater network in 2016:

 

    The Finest Hours: The IMAX Experience (Walt Disney Studios, January 2016);

 

    Warcraft: An IMAX 3D Experience (Universal Studios, March 2016);

 

    Batman v Superman: Dawn of Justice: The IMAX Experience (Warner Bros. Pictures, March 2016);

 

    The Jungle Book: The IMAX Experience (Walt Disney Studios, April 2016);

 

    Captain America: Civil War: The IMAX Experience (Walt Disney Studios, May 2016);

 

    Alice in Wonderland: Through the Looking Glass: The IMAX Experience (Walt Disney Studios, May 2016);

 

    Finding Dory: The IMAX Experience (Walt Disney Studios, June 2016);

 

    Tarzan: The IMAX Experience (Warner Bros. Pictures, July 2016);

 

    Knights of the Roundtable: King Arthur: The IMAX Experience (Warner Bros. Pictures, July 2016);

 

    Suicide Squad: The IMAX Experience (Warner Bros. Pictures, August 2016);

 

    Geostorm: The IMAX Experience (Warner Bros. Pictures, October 2016);

 

    Doctor Strange: An IMAX 3D Experience (Walt Disney Studios, November 2016);

 

    Fantastic Beasts and Where to Find Them: The IMAX Experience (Warner Bros. Pictures, November 2016); and

 

    Rogue One: An IMAX 3D Experience (Walt Disney Studios, December 2016).

The Company remains in active negotiations with all of the major Hollywood studios for additional films to fill out its short and long-term film slate, and anticipates that a similar number of IMAX DMR films will be released to the IMAX network in 2015 to the 40 films that were released to the IMAX network in 2014.

 

5


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

 

     Three Months  
     Ended March 31,  
     2015     2014  

Revenues

    

Equipment and product sales

   $ 14,436     $ 6,354  

Services

     31,716       28,872  

Rentals

     13,814       10,791  

Finance income

     2,245       2,180  
  

 

 

   

 

 

 
  62,211     48,197  
  

 

 

   

 

 

 

Costs and expenses applicable to revenues

Equipment and product sales

  7,540     3,719  

Services

  14,807     14,350  

Rentals

  3,883     3,720  
  

 

 

   

 

 

 
  26,230     21,789  
  

 

 

   

 

 

 

Gross margin

  35,981     26,408  

Selling, general and administrative expenses
(including share-based compensation expense of $5.6 million for the three months ended March 31, 2015 (2014 - expense of $3.2 million))

  28,352     21,312  

Research and development

  4,542     3,599  

Amortization of intangibles

  430     402  

Receivable provisions, net of recoveries

  5     287  
  

 

 

   

 

 

 

Income from operations

  2,652     808  

Interest income

  246     16  

Interest expense

  (304   (266
  

 

 

   

 

 

 

Income from operations before income taxes

  2,594     558  

Provision for income taxes

  (675   (72

Loss from equity-accounted investments, net of tax

  (434   (262
  

 

 

   

 

 

 

Income from continuing operations

  1,485     224  

Net income from discontinued operations, net of tax

  —       355  
  

 

 

   

 

 

 

Net income

$ 1,485   $ 579  

Less: Net income attributable to non-controlling interests

  (1,094   —    
  

 

 

   

 

 

 

Net income attributable to Common Shareholders

$ 391   $ 579  
  

 

 

   

 

 

 

Net income per share - basic & diluted:

Net income per share from continuing operations

$ —     $ —    

Net income per share from discontinued operations

  —       0.01  
  

 

 

   

 

 

 
$ —     $ 0.01  
  

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

Basic

  69,210     67,908  

Fully Diluted

  70,676     69,321  

Additional Disclosure:

Depreciation and amortization(1)

$ 9,633   $ 7,555  

 

(1) Includes $0.2 million of amortization of deferred financing costs charged to interest expense for the three months ended March 31, 2015 (2014 - $0.1 million).

 

6


IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

 

     As at
March 31,
2015
    As at
December 31,
2014
 
     (unaudited)        

Assets

    

Cash and cash equivalents

   $ 140,342     $ 106,503  

Accounts receivable, net of allowance for doubtful accounts of $946 (December 31, 2014 — $947)

     66,187       76,051  

Financing receivables

     105,228       105,700  

Inventories

     25,631       17,063  

Prepaid expenses

     7,026       4,946  

Film assets

     14,921       15,163  

Property, plant and equipment

     201,926       183,424  

Other assets

     24,448       23,047  

Deferred income taxes

     23,799       23,058  

Other intangible assets

     27,305       27,551  

Goodwill

     39,027       39,027  
  

 

 

   

 

 

 

Total assets

$ 675,840   $ 621,533  
  

 

 

   

 

 

 

Liabilities

Bank indebtedness

$ 16,080   $ 4,710  

Accounts payable

  27,039     26,145  

Accrued and other liabilities

  59,412     75,425  

Deferred revenue

  95,694     88,566  
  

 

 

   

 

 

 

Total liabilities

  198,225     194,846  
  

 

 

   

 

 

 

Commitments and contingencies

Non-controlling interests

  83,223     43,912  
  

 

 

   

 

 

 

Shareholders’ equity

Capital stock, common shares — no par value. Authorized — unlimited number.

Issued and outstanding — 69,586,041 (December 31, 2014 — 68,988,050)

  361,451     344,862  

Other equity

  43,990     47,319  

Accumulated deficit

  (6,090   (6,259

Accumulated other comprehensive loss

  (4,959   (3,147
  

 

 

   

 

 

 

Total shareholders’ equity

  394,392     382,775  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

$ 675,840   $ 621,533  
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)

 

     Three Months
Ended March 31,
 
     2015     2014  

Cash provided by (used in):

    

Operating Activities

    

Net income

   $ 1,485     $ 579  

Net income from discontinued operations

     —         (355

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     9,633       7,555  

Write-downs, net of recoveries

     128       518  

Change in deferred income taxes

     191       (75

Stock and other non-cash compensation

     5,666       3,281  

Unrealized foreign currency exchange loss

     1,351       646  

Loss from equity-accounted investments

     785       346  

Gain on non-cash contribution to equity-accounted investees

     (352     —    

Investment in film assets

     (3,013     (1,888

Changes in other non-cash operating assets and liabilities

     (9,805     2,755  

Net cash provided by operating activities from discontinued operations

     —         572  
  

 

 

   

 

 

 

Net cash provided by operating activities

  6,069     13,934  
  

 

 

   

 

 

 

Investing Activities

Purchase of property, plant and equipment

  (22,582   (7,927

Investment in joint revenue sharing equipment

  (4,815   (5,506

Acquisition of other intangible assets

  (665   (287
  

 

 

   

 

 

 

Net cash used in investing activities

  (28,062   (13,720
  

 

 

   

 

 

 

Financing Activities

Issuance of subsidiary shares to a non-controlling interest

  40,000     —    

Share issuance costs from the issuance of subsidiary shares to a non-controlling interest

  (2,000   —    

Common shares issued - stock options exercised

  11,407     742  

Increase in bank indebtedness

  11,371     —    

Settlement of restricted share units

  (3,905   (789

Credit facility amendment fees paid

  (1,003   —    
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

  55,870     (47
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

  (38   (21
  

 

 

   

 

 

 

Increase in cash and cash equivalents during the period

  33,839     146  

Cash and cash equivalents, beginning of period

  106,503     29,546  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

$ 140,342   $ 29,692  
  

 

 

   

 

 

 

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment includes the design, manufacture, sale or lease of IMAX theater projection system equipment. The theater system maintenance segment includes the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment includes the provision of IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment includes the production of films and the performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months Ended March 31,  
     2015      2014  

Revenue

     

IMAX Theater Systems

     

IMAX Systems

     

Sales and sales-type leases

   $ 8,616      $ 4,507  

Ongoing rent, fees, and finance income

     3,498        3,253  

Other

     3,425        1,512  
  

 

 

    

 

 

 
  15,539     9,272  
  

 

 

    

 

 

 

Theater system maintenance

  8,850     8,195  
  

 

 

    

 

 

 

Joint revenue sharing arrangements

  15,868     10,856  
  

 

 

    

 

 

 

Film

Production and IMAX DMR

  17,676     15,185  

Film distribution and post-production

  4,278     4,689  
  

 

 

    

 

 

 
  21,954     19,874  
  

 

 

    

 

 

 

Total

$ 62,211   $ 48,197  
  

 

 

    

 

 

 

Gross margin

IMAX Theater Systems

IMAX systems(1)

Sales and sales-type leases

$ 4,907   $ 1,659  

Ongoing rent, fees, and finance income

  3,278     3,114  

Other

  (40   (438
  

 

 

    

 

 

 
  8,145     4,335  
  

 

 

    

 

 

 

Theater system maintenance

  3,281     3,001  
  

 

 

    

 

 

 

Joint revenue sharing arrangements(1)

  10,617     7,283  
  

 

 

    

 

 

 

Film

Production and IMAX DMR(1)

  13,225     11,074  

Film distribution and post-production

  713     715  
  

 

 

    

 

 

 
  13,938     11,789  
  

 

 

    

 

 

 

Total

$ 35,981   $ 26,408  
  

 

 

    

 

 

 

 

(1) IMAX systems include marketing and commission costs of $0.3 million for the three months ended March 31, 2015 (2014 — $0.2 million). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.1 million for the three months ended March 31, 2015 (2014 — $0.2 million). Production and DMR segment margins include marketing costs of $1.3 million for the three months ended March 31, 2015 (2014 — $1.1 million). Distribution segment margins include marketing cost recovery of $0.1 million for the three months ended March 31, 2015 (2014 — expense of $0.2 million).

 

9


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.

The Credit Facility provides that the Company will be required at all times to satisfy a Minimum Liquidity Test (as defined in the Credit Agreement) of at least $50 million. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $90.0 million until December 30, 2015, which requirement increases to $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1.0 until December 30, 2015, which requirement decreases to (i) 2.25:1.0 on December 31, 2015; (ii) 2.0:1.0 on December 31, 2016; and (iii) 1.75:1.0 on December 31, 2017. The ratio of total debt to EBITDA was 0.14:1 as at March 31, 2015, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $16.1 million. EBITDA is calculated as follows:

 

     For the
3 months ended
March 31, 2015
     For the
12 months ended
March 31, 2015(1)
 
(In thousands of U.S Dollars)              

Net income

   $ 1,485      $ 43,075   

Add (subtract):

     

Loss from equity accounted investments

     434        1,243   

Provision for income taxes

     675        15,069   

Interest expense, net of interest income

     58        327   

Depreciation and amortization, including film asset amortization

     9,467        35,273   

Write-downs net of recoveries including asset impairments and receivable provisions

     128        4,904   

Stock and other non-cash compensation

     5,666        17,852   

EBITDA attributable to non-controlling
interests(2)

     (1,933      (5,870
  

 

 

    

 

 

 
$ 15,980   $ 111,873   
  

 

 

    

 

 

 

 

(1) Ratio of funded debt calculated using twelve months ended EBITDA.
(2) The EBITDA calculation specified for purposes of the minimum EBITDA covenant excludes the reduction in EBITDA from the Company’s non-controlling interests.

 

10


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended March 31, 2015 vs. 2014:

The Company reported net income of $1.5 million or $0.02 per basic and diluted share for the first quarter of 2015, as compared to $0.6 million or $0.01 per basic and diluted share for the first quarter of 2014. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $6.1 million or $0.09 per diluted share for the first quarter of 2015 as compared to adjusted net income of $3.3 million or $0.05 per diluted share for the first quarter of 2014. Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation and the related tax impact, was $5.0 million or $0.07 per diluted share for the first quarter of 2015 as compared to adjusted net income attributable to common shareholders of $3.3 million or $0.05 per diluted share for the first quarter of 2014. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measures, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

 

     Three Months Ended
March 31, 2015
    Three Months Ended
March 31, 2014
 
     Net Income      Diluted EPS     Net Income      Diluted EPS  

Reported net income

   $ 1,485      $ 0.02  (1)    $ 579      $ 0.01  

Adjustments:

          

Stock-based compensation

     5,575        0.08         3,188        0.05  

Tax impact on items listed above

     (962      (0.01 )       (515      (0.01
  

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted net income

  6,098     0.09  (1)    3,252     0.05  

Net income attributable to non-controlling interests

  (1,094   (0.02 )     —       —    
  

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted net income attributable to common shareholders

$ 5,004   $ 0.07  (1)  $ 3,252   $ 0.05  
  

 

 

    

 

 

   

 

 

    

 

 

 

Weighted average diluted shares outstanding

  70,676       69,321  
     

 

 

      

 

 

 

 

(1) Includes impact of $0.2 million of accretion charges associated with redeemable common stock.

Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

     For the
3 months ended
March 31, 2015
 
(In thousands of U.S. Dollars)       

Net cash provided by operating activities

   $ 6,069  

Net cash used in investing activities

     (28,062
  

 

 

 

Free cash flow

$ (21,993
  

 

 

 

 

11